Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:01 pm Sale |
2023-12-31 | 13G | Oculis Holding AG OCS |
Novartis Bioventures Ltd | 1,713,521 4.700% |
-464,381 (-21.32%) |
Filing History |
| 2023-03-13 08:01 am Purchase |
2023-03-02 | 13G | Oculis Holding AG OCS |
Novartis Bioventures Ltd | 2,177,902 6.700% |
2,177,902 (New Position) |
Filing History |
| 2022-02-11 4:32 pm Sale |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Novartis Bioventures Ltd | 673,360 2.290% |
-967,786 (-58.97%) |
Filing History |
| 2022-02-11 4:31 pm Sale |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Novartis Bioventures Ltd | 1,757,057 3.710% |
-1,234,648 (-41.27%) |
Filing History |
| 2022-02-11 4:30 pm Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novartis Bioventures Ltd | 476,085 1.800% |
-1,991,875 (-80.71%) |
Filing History |
| 2022-02-11 4:30 pm Sale |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Novartis Bioventures Ltd | 910,747 2.370% |
-1,196,497 (-56.78%) |
Filing History |
| 2021-02-23 4:05 pm Purchase |
2021-02-16 | 13G | Adicet Bio, Inc. ACET |
Novartis Bioventures Ltd | 1,366,864 4.360% |
98,011 (+7.72%) |
Filing History |
| 2021-02-01 5:14 pm Sale |
2020-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Novartis Bioventures Ltd | 1,641,146 7.700% |
-126,995 (-7.18%) |
Filing History |
| 2021-02-01 4:09 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Novartis Bioventures Ltd | 2,991,705 6.690% |
2,991,705 (New Position) |
Filing History |
| 2021-02-01 3:50 pm Sale |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novartis Bioventures Ltd | 2,467,960 9.890% |
-1,075,107 (-30.34%) |
Filing History |
| 2021-02-01 08:34 am Purchase |
2020-12-31 | 13G | Adicet Bio, Inc. ACET |
Novartis Bioventures Ltd | 1,268,853 6.500% |
14,115 (+1.12%) |
Filing History |
| 2021-01-29 09:07 am Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Novartis Bioventures Ltd | 2,107,244 5.520% |
2,107,244 (New Position) |
Filing History |
| 2020-09-22 4:05 pm Purchase |
2020-09-15 | 13G | Adicet Bio, Inc. ACET |
Novartis Bioventures Ltd | 1,254,738 6.400% |
1,254,738 (New Position) |
Filing History |
| 2020-05-15 06:05 am Sale |
2020-05-13 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
Novartis Bioventures Ltd | 42,349 1.570% |
-167,495 (-79.82%) |
Filing History |